BUSINESS WIRE Pro-ficiency to Accelerate Growth with Major Investment from NovaQuest Private Equity 2.23.21
BUSINESS WIRE Mycovia Pharmaceuticals Announces Positive Topline Results from Phase 3 VIOLET Studies of Oteseconazole in Patients with Recurrent Vulvovaginal Candidiasis 12.9.20
Business Wire Mycovia Pharmaceuticals Announces Partnership with Gedeon Richter to Commercialize and Manufacture VT-1161 for Recurrent Vulvovaginal Candidiasis (RVVC) 10.16.19